Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives

Samankaltaisia teoksia

• Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities
  Tekijä: Wang, Ying, et al.
  Julkaistu: (2016)
• Discovery of Anilinopyrimidines as Dual Inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and Cellular Activity
  Tekijä: Zhan, Zhengsheng, et al.
  Julkaistu: (2014)
• Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors
  Tekijä: Li, Chunpu, et al.
  Julkaistu: (2015)
• Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors
  Tekijä: Liu, Xiaobo, et al.
  Julkaistu: (2018)
• Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
  Tekijä: Wu, Xiaowei, et al.
  Julkaistu: (2021)